VCYT
VERACYTE, INC.
NASDAQ · Healthcare · Biotechnology · US
$51.11
+1.62%Forward multiples
Based on analyst estimates
- P/E forward
- 27.55x
- P/E 2026E
- 26.72x
- P/E 2027E
- 26.24x
- P/E 2028E
- 24.41x
- P/S forward
- 6.42x
Trailing multiples
Trailing twelve months
- P/E TTM
- 35.49x
- PEG TTM
- 1.23x
- Price / book
- 2.96x
- Price / sales
- 7.31x
- Price / cash flow
- 23.03x
Enterprise value
- Enterprise value
- $3.7B
- EV / sales
- 6.52x
- EV / EBITDA
- 28.23x
- EV / EBIT
- 38.27x
- Market cap
- $4.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026